Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Anne Fuhlbrigge

Concepts (429)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Asthma
98
2025
1774
9.740
 Why?
Anti-Asthmatic Agents
28
2025
253
3.330
 Why?
Adrenal Cortex Hormones
28
2025
480
3.280
 Why?
Forced Expiratory Volume
19
2019
448
1.530
 Why?
Pulmonary Disease, Chronic Obstructive
11
2022
919
1.360
 Why?
Severity of Illness Index
20
2020
2922
0.940
 Why?
Administration, Inhalation
25
2025
570
0.940
 Why?
Anti-Inflammatory Agents
10
2016
477
0.850
 Why?
Albuterol
5
2015
73
0.820
 Why?
Bronchodilator Agents
12
2016
184
0.820
 Why?
Lung Transplantation
10
2017
329
0.790
 Why?
Budesonide
14
2016
49
0.780
 Why?
Remote Consultation
4
2025
66
0.730
 Why?
Nedocromil
11
2016
20
0.700
 Why?
Humans
129
2025
144671
0.680
 Why?
Nasal Polyps
1
2021
59
0.670
 Why?
Self Report
3
2023
869
0.670
 Why?
Endpoint Determination
2
2020
84
0.650
 Why?
Pharmacogenetics
2
2015
172
0.650
 Why?
Food Hypersensitivity
1
2022
164
0.620
 Why?
Sinusitis
1
2021
227
0.580
 Why?
Virus Diseases
1
2021
218
0.570
 Why?
Lung
7
2019
4089
0.560
 Why?
Glucocorticoids
4
2022
528
0.560
 Why?
Physicians
2
2021
949
0.550
 Why?
Symptom Assessment
1
2019
136
0.540
 Why?
Hospitalization
13
2020
2446
0.520
 Why?
Sleep Apnea, Obstructive
1
2021
300
0.510
 Why?
Androstadienes
3
2012
75
0.500
 Why?
Bone Density
2
2014
484
0.490
 Why?
Child
53
2022
22600
0.480
 Why?
Disease Progression
14
2020
2847
0.480
 Why?
Oxygen Inhalation Therapy
4
2020
181
0.480
 Why?
Managed Care Programs
8
2008
140
0.480
 Why?
Male
82
2025
72431
0.460
 Why?
Precision Medicine
1
2020
454
0.450
 Why?
Emergency Service, Hospital
9
2013
2325
0.450
 Why?
Adult
47
2025
40489
0.450
 Why?
Adrenergic beta-2 Receptor Agonists
4
2020
26
0.430
 Why?
Cost Savings
1
2015
85
0.430
 Why?
Female
81
2025
78304
0.430
 Why?
Practice Patterns, Physicians'
7
2020
1360
0.420
 Why?
Patient Reported Outcome Measures
1
2018
496
0.410
 Why?
Peak Expiratory Flow Rate
2
2011
25
0.390
 Why?
Cost-Benefit Analysis
7
2022
638
0.390
 Why?
Phenotype
6
2025
3147
0.380
 Why?
Middle Aged
40
2025
35971
0.380
 Why?
Comorbidity
4
2021
1652
0.350
 Why?
Academic Medical Centers
3
2024
545
0.340
 Why?
Surveys and Questionnaires
14
2022
6041
0.330
 Why?
Adolescent
37
2019
22409
0.330
 Why?
Medical Records Systems, Computerized
3
2008
94
0.320
 Why?
Administration, Oral
6
2021
851
0.320
 Why?
Mentors
1
2012
214
0.320
 Why?
Respiratory Function Tests
10
2015
541
0.310
 Why?
Quality of Life
12
2023
3183
0.310
 Why?
United States
23
2022
16018
0.300
 Why?
Interprofessional Relations
3
2021
275
0.300
 Why?
Faculty, Medical
1
2012
301
0.300
 Why?
Spirometry
8
2020
231
0.290
 Why?
Child, Preschool
31
2016
11790
0.290
 Why?
Child Development
1
2014
482
0.290
 Why?
Treatment Outcome
16
2025
11735
0.290
 Why?
Group Practice
1
2008
6
0.280
 Why?
Anti-Allergic Agents
2
2008
40
0.280
 Why?
Oxygen
3
2018
984
0.270
 Why?
Computer Simulation
1
2012
1021
0.270
 Why?
Aged
22
2022
25955
0.260
 Why?
Dyspnea
3
2022
250
0.250
 Why?
Drug Utilization
4
2005
167
0.240
 Why?
Randomized Controlled Trials as Topic
8
2020
1742
0.240
 Why?
Primary Health Care
5
2025
1730
0.240
 Why?
Primary Graft Dysfunction
2
2017
33
0.240
 Why?
Quality Assurance, Health Care
1
2008
341
0.240
 Why?
Follow-Up Studies
17
2017
5414
0.230
 Why?
Bronchiolitis Obliterans
3
2017
61
0.230
 Why?
Respiratory Sounds
1
2006
103
0.230
 Why?
Gift Giving
1
2005
9
0.230
 Why?
Diagnostic Techniques, Respiratory System
1
2005
5
0.230
 Why?
Allergists
2
2022
13
0.220
 Why?
Genetic Testing
1
2008
480
0.220
 Why?
Delivery of Health Care
2
2021
944
0.220
 Why?
Cohort Studies
14
2013
5957
0.200
 Why?
Specialization
2
2025
136
0.200
 Why?
Medication Adherence
2
2023
540
0.200
 Why?
Retrospective Studies
18
2024
17149
0.200
 Why?
Natural Language Processing
1
2025
103
0.200
 Why?
Time Factors
10
2020
7140
0.200
 Why?
Massachusetts
5
2016
180
0.200
 Why?
Leadership
2
2022
400
0.200
 Why?
Antibodies, Monoclonal
2
2008
1505
0.200
 Why?
Medicine
1
2025
125
0.200
 Why?
Genetic Variation
1
2008
985
0.190
 Why?
Rhinitis, Allergic, Perennial
1
2003
20
0.190
 Why?
Steroids
8
2011
159
0.190
 Why?
Recurrence
5
2013
1136
0.190
 Why?
Genetic Predisposition to Disease
2
2025
2350
0.190
 Why?
Health Status
1
2008
834
0.190
 Why?
Predictive Value of Tests
9
2012
2117
0.180
 Why?
Beclomethasone
1
2022
8
0.180
 Why?
Multicenter Studies as Topic
4
2018
408
0.180
 Why?
Young Adult
11
2019
14122
0.180
 Why?
Prevalence
4
2022
2839
0.180
 Why?
Models, Theoretical
4
2007
578
0.180
 Why?
Tiotropium Bromide
2
2018
5
0.170
 Why?
Desensitization, Immunologic
1
2022
89
0.170
 Why?
Nebulizers and Vaporizers
2
2020
62
0.170
 Why?
Biomarkers
3
2021
4261
0.170
 Why?
Social Class
2
2022
265
0.170
 Why?
Patient Preference
1
2023
226
0.160
 Why?
Churg-Strauss Syndrome
1
2020
27
0.160
 Why?
Bronchoconstriction
3
2011
29
0.160
 Why?
Pulmonologists
1
2020
14
0.160
 Why?
Granulomatosis with Polyangiitis
1
2020
47
0.160
 Why?
Capacity Building
1
2021
62
0.160
 Why?
Muscarinic Antagonists
1
2020
30
0.160
 Why?
Agammaglobulinemia
1
2020
36
0.160
 Why?
Electronic Health Records
2
2025
1176
0.150
 Why?
Physician-Patient Relations
2
2021
589
0.150
 Why?
Practice Guidelines as Topic
5
2020
1569
0.150
 Why?
Risk Factors
12
2018
10796
0.150
 Why?
Air Pollution, Indoor
2
2002
182
0.150
 Why?
Treatment Adherence and Compliance
1
2019
27
0.140
 Why?
Exercise Test
1
2022
626
0.140
 Why?
Receptors, IgE
2
2009
43
0.140
 Why?
Allergens
1
2021
387
0.130
 Why?
Prognosis
8
2017
4312
0.130
 Why?
Vitamin D
2
2012
400
0.130
 Why?
Fossil Fuels
1
1997
10
0.130
 Why?
Hypersensitivity
1
2020
253
0.130
 Why?
Alemtuzumab
1
2017
15
0.130
 Why?
Photopheresis
1
2017
9
0.130
 Why?
Drug Prescriptions
2
2011
283
0.130
 Why?
Respiration
1
2017
206
0.130
 Why?
Biological Products
1
2020
256
0.130
 Why?
Physicians, Primary Care
3
2021
209
0.130
 Why?
Respiration Disorders
1
1997
78
0.120
 Why?
Emergency Medical Services
2
2007
695
0.120
 Why?
Statistics, Nonparametric
1
2017
427
0.120
 Why?
Drug Therapy, Combination
5
2020
1044
0.120
 Why?
Drug Combinations
3
2012
393
0.120
 Why?
Drug Monitoring
1
2020
396
0.120
 Why?
Immunomodulation
1
2017
98
0.120
 Why?
Socioeconomic Factors
4
2022
1322
0.120
 Why?
Tobacco Smoke Pollution
2
2010
227
0.120
 Why?
Scopolamine Derivatives
1
2015
3
0.120
 Why?
Breath Tests
2
2008
77
0.120
 Why?
Immunoglobulin G
1
2020
886
0.120
 Why?
Aged, 80 and over
6
2019
8284
0.120
 Why?
Embolism, Fat
1
2015
11
0.120
 Why?
Cholinergic Antagonists
1
2015
23
0.110
 Why?
Patient Admission
1
2018
220
0.110
 Why?
Transplants
1
2015
39
0.110
 Why?
National Heart, Lung, and Blood Institute (U.S.)
1
2015
103
0.110
 Why?
Fluticasone-Salmeterol Drug Combination
2
2012
7
0.110
 Why?
Carcinoma, Bronchogenic
1
2015
20
0.110
 Why?
Genomics
2
2018
831
0.110
 Why?
Longitudinal Studies
6
2017
2942
0.110
 Why?
Graft Rejection
2
2013
512
0.110
 Why?
Referral and Consultation
1
2021
852
0.110
 Why?
Respiratory Tract Infections
2
2012
395
0.100
 Why?
Overweight
2
2011
606
0.100
 Why?
Ambulatory Care Information Systems
2
2005
5
0.100
 Why?
Prednisolone
1
2014
66
0.100
 Why?
Postoperative Complications
2
2017
2950
0.100
 Why?
Risk
4
2015
911
0.100
 Why?
Telemedicine
1
2023
957
0.100
 Why?
Guideline Adherence
3
2020
586
0.100
 Why?
Education, Medical, Continuing
2
2005
133
0.100
 Why?
Airway Obstruction
1
2015
153
0.100
 Why?
Environmental Exposure
3
2006
574
0.100
 Why?
Bronchial Hyperreactivity
3
2010
96
0.100
 Why?
Forecasting
1
2015
391
0.100
 Why?
Transplantation
1
2013
33
0.100
 Why?
Office Visits
4
2011
92
0.100
 Why?
Quality Improvement
1
2022
1287
0.100
 Why?
Insurance Claim Review
1
2013
83
0.090
 Why?
Growth
1
2012
49
0.090
 Why?
Double-Blind Method
5
2010
2033
0.090
 Why?
Medicare
2
2022
899
0.090
 Why?
Research
1
2015
431
0.090
 Why?
Costs and Cost Analysis
1
2013
221
0.090
 Why?
Methacholine Chloride
3
2008
50
0.090
 Why?
Peer Group
2
2012
256
0.090
 Why?
Cytomegalovirus Infections
2
2012
205
0.090
 Why?
Metered Dose Inhalers
1
2012
8
0.090
 Why?
Cost of Illness
3
2003
322
0.090
 Why?
Drug Dosage Calculations
1
2011
27
0.090
 Why?
Feedback
1
2012
181
0.090
 Why?
Logistic Models
5
2017
2114
0.090
 Why?
Mycoses
1
2012
88
0.090
 Why?
Antibodies, Monoclonal, Humanized
2
2008
990
0.090
 Why?
Antifungal Agents
1
2012
150
0.090
 Why?
Effect Modifier, Epidemiologic
1
2011
8
0.090
 Why?
Multivariate Analysis
7
2017
1537
0.090
 Why?
Body Height
1
2012
199
0.080
 Why?
Professional Role
1
2012
159
0.080
 Why?
Medication Errors
1
2012
82
0.080
 Why?
Morbidity
2
2022
322
0.080
 Why?
Epidemiologic Studies
1
2011
68
0.080
 Why?
Pneumococcal Vaccines
1
2012
129
0.080
 Why?
Mycobacterium
1
2012
116
0.080
 Why?
Obesity
3
2015
3070
0.080
 Why?
Diagnostic Errors
1
2012
177
0.080
 Why?
Patient Readmission
1
2016
765
0.080
 Why?
Program Development
1
2012
368
0.080
 Why?
Drug Resistance
1
2011
145
0.080
 Why?
Secondary Prevention
1
2012
255
0.080
 Why?
Probability
1
2011
309
0.080
 Why?
Vitamin D Deficiency
1
2012
187
0.080
 Why?
Lung Diseases
1
2017
781
0.080
 Why?
Chi-Square Distribution
2
2017
524
0.080
 Why?
Bronchial Provocation Tests
2
2008
47
0.080
 Why?
Fluticasone
2
2008
53
0.080
 Why?
Pragmatic Clinical Trials as Topic
2
2020
133
0.080
 Why?
Incidence
5
2020
2892
0.080
 Why?
Decision Support Techniques
2
2012
461
0.080
 Why?
Immunoglobulin E
2
2008
315
0.080
 Why?
Vital Capacity
4
2017
290
0.070
 Why?
Receptors, Corticotropin-Releasing Hormone
1
2009
28
0.070
 Why?
Lectins, C-Type
1
2009
59
0.070
 Why?
Ambulatory Care
2
2011
607
0.070
 Why?
Smoking
3
2017
1467
0.070
 Why?
Algorithms
1
2017
1844
0.070
 Why?
Health Services
2
2007
114
0.070
 Why?
Medication Therapy Management
1
2010
72
0.070
 Why?
Proportional Hazards Models
1
2012
1322
0.070
 Why?
Odds Ratio
4
2017
1076
0.070
 Why?
Health Knowledge, Attitudes, Practice
2
2012
1406
0.070
 Why?
Pandemics
3
2022
1700
0.070
 Why?
Surgical Wound Infection
1
2012
330
0.070
 Why?
Acute Disease
1
2011
1029
0.070
 Why?
Kaplan-Meier Estimate
3
2016
967
0.070
 Why?
Vitamin K Epoxide Reductases
1
2008
11
0.070
 Why?
Cytochrome P-450 CYP2C9
1
2008
19
0.070
 Why?
Cross-Sectional Studies
6
2010
5870
0.070
 Why?
Eosinophil Cationic Protein
1
2008
9
0.070
 Why?
Adrenergic beta-Agonists
1
2008
92
0.070
 Why?
Mixed Function Oxygenases
1
2008
49
0.070
 Why?
Program Evaluation
1
2012
941
0.070
 Why?
Aryl Hydrocarbon Hydroxylases
1
2008
45
0.070
 Why?
Genetic Techniques
1
2008
67
0.070
 Why?
Quality-Adjusted Life Years
2
2006
122
0.070
 Why?
Insurance, Pharmaceutical Services
1
2008
24
0.070
 Why?
State Health Plans
1
2008
28
0.070
 Why?
Markov Chains
2
2006
130
0.070
 Why?
Cost Sharing
1
2008
20
0.070
 Why?
Smoking Cessation
1
2012
436
0.070
 Why?
Trastuzumab
1
2008
117
0.070
 Why?
Reimbursement Mechanisms
1
2008
79
0.070
 Why?
Antibodies, Anti-Idiotypic
1
2007
50
0.070
 Why?
Chronic Disease
3
2017
1810
0.060
 Why?
Omalizumab
1
2007
43
0.060
 Why?
Mycobacterium Infections, Nontuberculous
1
2012
368
0.060
 Why?
Exercise Tolerance
2
2022
282
0.060
 Why?
Factor Analysis, Statistical
1
2008
290
0.060
 Why?
Health Surveys
2
2006
517
0.060
 Why?
Warfarin
1
2008
173
0.060
 Why?
Influenza Vaccines
1
2012
530
0.060
 Why?
Interviews as Topic
1
2011
905
0.060
 Why?
Antiviral Agents
1
2012
765
0.060
 Why?
Animals, Domestic
1
2006
17
0.060
 Why?
Databases, Factual
1
2012
1494
0.060
 Why?
Tomography, X-Ray Computed
1
2017
2754
0.060
 Why?
Lung Diseases, Interstitial
1
2013
660
0.060
 Why?
Health Services Accessibility
2
2021
1098
0.060
 Why?
Animals
2
2025
37948
0.060
 Why?
Physicians, Family
2
2004
173
0.060
 Why?
Eosinophils
1
2008
316
0.060
 Why?
Biomedical Research
1
2012
712
0.060
 Why?
Health Benefit Plans, Employee
1
2005
25
0.060
 Why?
Database Management Systems
1
2005
50
0.060
 Why?
Hip Fractures
1
2006
86
0.050
 Why?
Health Policy
1
2008
398
0.050
 Why?
Models, Biological
1
2012
1811
0.050
 Why?
Patients
1
2006
182
0.050
 Why?
Insurance Coverage
1
2006
243
0.050
 Why?
Utilization Review
1
2004
39
0.050
 Why?
Infant
3
2008
10023
0.050
 Why?
Patient Education as Topic
3
2005
771
0.050
 Why?
Body Mass Index
3
2015
2419
0.050
 Why?
Gene Expression Profiling
1
2011
1766
0.050
 Why?
Prenatal Exposure Delayed Effects
1
2010
641
0.050
 Why?
Clinical Competence
1
2012
1237
0.050
 Why?
Medicaid
1
2008
464
0.050
 Why?
Vaccination
1
2012
1419
0.050
 Why?
Nitric Oxide
1
2008
894
0.050
 Why?
Attitude to Health
1
2006
431
0.050
 Why?
Mass Screening
1
2012
1348
0.050
 Why?
Sex Factors
3
2016
2104
0.050
 Why?
Anticoagulants
1
2008
729
0.050
 Why?
Case Management
1
2003
68
0.050
 Why?
Parents
3
2006
1395
0.050
 Why?
Clinical Trials as Topic
2
2005
1056
0.050
 Why?
Puerto Rico
1
2022
59
0.050
 Why?
Choice Behavior
1
2004
179
0.050
 Why?
Anti-Bacterial Agents
2
2004
1928
0.040
 Why?
Symptom Flare Up
1
2022
37
0.040
 Why?
Sputum
1
2004
308
0.040
 Why?
Circadian Rhythm
1
2006
510
0.040
 Why?
Academies and Institutes
1
2022
58
0.040
 Why?
Health Services Research
1
2004
392
0.040
 Why?
Lung Neoplasms
1
2015
2660
0.040
 Why?
Minority Groups
1
2003
283
0.040
 Why?
Survival Rate
2
2016
2089
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2020
76
0.040
 Why?
Electronics
1
2021
69
0.040
 Why?
Clinical Trials, Phase III as Topic
1
2020
116
0.040
 Why?
Sample Size
1
2020
120
0.040
 Why?
Efficiency
1
2021
104
0.040
 Why?
Health Care Reform
1
2021
107
0.040
 Why?
Schools, Medical
1
2021
158
0.040
 Why?
Patient Compliance
2
2016
587
0.040
 Why?
Risk Assessment
3
2020
3729
0.040
 Why?
Patient Selection
2
2020
727
0.040
 Why?
Language
1
2022
323
0.040
 Why?
Stress, Psychological
1
2007
1148
0.040
 Why?
Time
1
2019
86
0.040
 Why?
Health Education
1
2002
345
0.040
 Why?
Cluster Analysis
2
2014
516
0.040
 Why?
Quality of Health Care
1
2003
692
0.030
 Why?
Poland
1
2017
34
0.030
 Why?
Bronchitis, Chronic
1
2017
16
0.030
 Why?
Republic of Korea
1
2017
42
0.030
 Why?
Cooperative Behavior
1
2021
464
0.030
 Why?
Patient-Centered Care
1
2003
545
0.030
 Why?
Sensitivity and Specificity
3
2013
1995
0.030
 Why?
Nitrogen Dioxide
1
1997
46
0.030
 Why?
Geography
1
2018
203
0.030
 Why?
Aftercare
1
2019
222
0.030
 Why?
Monitoring, Physiologic
2
2012
288
0.030
 Why?
Long-Term Care
1
2018
117
0.030
 Why?
Self Concept
1
2019
256
0.030
 Why?
Netherlands
1
2016
82
0.030
 Why?
Antineoplastic Agents
1
2008
2201
0.030
 Why?
Pediatrics
1
2005
1121
0.030
 Why?
Tuberculosis, Pulmonary
1
2017
131
0.030
 Why?
Forced Expiratory Flow Rates
1
2015
10
0.030
 Why?
Formoterol Fumarate
1
2015
6
0.030
 Why?
Perception
1
2019
376
0.030
 Why?
Salmeterol Xinafoate
1
2015
20
0.030
 Why?
Ethanolamines
1
2015
14
0.030
 Why?
Receptors, Adrenergic, beta-2
1
2015
36
0.030
 Why?
Treatment Failure
1
2016
365
0.030
 Why?
Dose-Response Relationship, Drug
2
2011
2019
0.030
 Why?
Self Efficacy
1
2019
409
0.030
 Why?
Education
1
2015
105
0.030
 Why?
Polymorphism, Single Nucleotide
2
2016
2137
0.030
 Why?
Postoperative Period
1
2016
351
0.030
 Why?
Feasibility Studies
1
2020
1103
0.030
 Why?
Immunosuppressive Agents
2
2015
834
0.030
 Why?
Age Factors
3
2008
3329
0.030
 Why?
Fatal Outcome
1
2015
305
0.030
 Why?
Biopsy
2
2013
1079
0.030
 Why?
Pilot Projects
1
2020
1886
0.030
 Why?
Combined Modality Therapy
1
2017
1268
0.030
 Why?
Patient Acceptance of Health Care
1
2021
881
0.030
 Why?
Gene Expression
1
2018
1476
0.020
 Why?
Telephone
2
2005
176
0.020
 Why?
Echinocandins
1
2012
8
0.020
 Why?
Lipopeptides
1
2012
16
0.020
 Why?
Aspergillosis
1
2012
24
0.020
 Why?
Amphotericin B
1
2012
36
0.020
 Why?
Intention to Treat Analysis
1
2012
79
0.020
 Why?
Candidiasis
1
2012
64
0.020
 Why?
Tissue Donors
1
2015
413
0.020
 Why?
Transplantation, Homologous
1
2013
407
0.020
 Why?
Mycobacterium avium Complex
1
2012
88
0.020
 Why?
Age Distribution
2
2003
402
0.020
 Why?
Cromolyn Sodium
2
2001
6
0.020
 Why?
Hypoxia
1
2019
1193
0.020
 Why?
Leukotriene Antagonists
1
2011
23
0.020
 Why?
Extracorporeal Membrane Oxygenation
1
2015
387
0.020
 Why?
Triazoles
1
2012
184
0.020
 Why?
Self Care
2
2005
389
0.020
 Why?
Functional Residual Capacity
1
2010
7
0.020
 Why?
Reference Values
1
2012
794
0.020
 Why?
Colorado
1
2021
4558
0.020
 Why?
Costa Rica
1
2010
18
0.020
 Why?
Principal Component Analysis
1
2011
195
0.020
 Why?
Health
1
2010
81
0.020
 Why?
Genome-Wide Association Study
1
2016
1374
0.020
 Why?
Nontuberculous Mycobacteria
1
2012
210
0.020
 Why?
Inhalation
1
2010
29
0.020
 Why?
Environment
1
2011
306
0.020
 Why?
Observation
1
2008
54
0.020
 Why?
Sex Ratio
1
2008
16
0.020
 Why?
Least-Squares Analysis
1
2008
74
0.020
 Why?
Models, Econometric
1
2008
34
0.020
 Why?
Prospective Studies
2
2012
7994
0.020
 Why?
Health Services Administration
1
2007
9
0.020
 Why?
Treatment Refusal
1
2008
98
0.020
 Why?
Intelligence
1
2007
110
0.020
 Why?
Social Isolation
1
2007
73
0.020
 Why?
Puberty
1
2008
135
0.020
 Why?
Body Weight
1
2011
968
0.020
 Why?
Child Behavior Disorders
1
2007
118
0.020
 Why?
Exercise
1
2016
2183
0.010
 Why?
CD4-Positive T-Lymphocytes
1
2011
1129
0.010
 Why?
Genotype
1
2009
1847
0.010
 Why?
Insurance, Health
1
2007
308
0.010
 Why?
Bronchoconstrictor Agents
1
2003
14
0.010
 Why?
Organizational Innovation
1
2004
118
0.010
 Why?
Health Status Indicators
1
2004
167
0.010
 Why?
Case-Control Studies
1
2010
3603
0.010
 Why?
Systems Integration
1
2003
36
0.010
 Why?
Computer Systems
1
2003
55
0.010
 Why?
Motor Activity
1
2007
723
0.010
 Why?
Histamine H1 Antagonists
1
2002
24
0.010
 Why?
Drug Administration Schedule
1
2004
779
0.010
 Why?
Self Disclosure
1
2002
62
0.010
 Why?
Child Welfare
1
2004
231
0.010
 Why?
Administration, Intranasal
1
2002
93
0.010
 Why?
Confidence Intervals
1
2002
331
0.010
 Why?
Regression Analysis
1
2003
998
0.010
 Why?
Nurse's Role
1
2003
149
0.010
 Why?
Point-of-Care Systems
1
2003
188
0.010
 Why?
Health Care Surveys
1
2002
537
0.010
 Why?
Sex Distribution
1
2001
386
0.010
 Why?
Patient Satisfaction
1
2004
707
0.010
 Why?
Linear Models
1
2002
845
0.010
 Why?
Disease Management
1
2003
650
0.010
 Why?
Decision Support Systems, Clinical
1
2003
269
0.010
 Why?
Bronchoscopy
1
2000
227
0.010
 Why?
Caregivers
1
2007
1062
0.010
 Why?
Internet
1
2003
698
0.010
 Why?
Pregnancy
1
2010
7122
0.010
 Why?
Survival Analysis
1
2000
1370
0.010
 Why?
Infant, Newborn
1
2004
6399
0.010
 Why?
Fuhlbrigge's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (429) concept(s)
_
Co-Authors Expand Description
See all (16) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)